Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
What’s Next For FDA In Face Of Opposing Mifepristone Injunctions
Apr 09 2023
•
By
Brenda Sandburg
Dueling injunctions stay FDA approval of mifepristone approval and order agency not to alter its availability • Source: Shutterstock
More from US FDA
More from Agency Leadership